The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification [1]

Pediatric Blood and Cancer

Volumn 48, Issue 5, 2007, Pages 593-

  Parodi, Stefano ^a   Papio, Filippo ^a   Haupt, Riccardo ^a   Conte, Massimo ^a   De Bernardi, Bruno ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; HOMOVANILLIC ACID; VANILMANDELIC ACID;

CANCER REGISTRY; CANCER STAGING; CATECHOLAMINE URINE LEVEL; DISSEMINATED CANCER; ITALY; LETTER; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

CATECHOLAMINES; GENE AMPLIFICATION; HUMANS; INFANT; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; VANILMANDELIC ACID;

EID: 33947643789     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21035     Document Type: Letter

References (1)

1. Strenger V, Kerbl R, Dornbusch HJ, et al. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer 26 May 2006 [Epub ahead of print].